Dear Sir,
It is well known that systolic blood pressure (SBP) varies throughout the arterial tree (ie brachial artery vs ascending aorta). One previous study 1 has shown that SBP in the radial artery was higher by more than 10 mmHg than SBP in the ascending aorta. Elucidation of the clinical parameters correlated with peripheral-central SBP difference is potentially important, as central SBP would be expected to be a more sensitive marker than peripheral SBP for cardiovascular risk stratification. 2 When the cardiovascular risk of two subject groups having identical peripheral SBP levels but different aortic SBP levels is predicted on the basis of peripheral blood pressure, risk for the group with higher central SBP may be underestimated compared to that for subjects with lower aortic SBP. The present study made use of a commercially available device to elucidate the clinical characteristics related to peripheral-central SBP differences in a setting of cardiovascular risk assessment in a communitybased population.
Participants in the present study were selected randomly from the 40 to 79 year age group in the general population in Higashiyama (Tozan) town, Iwate, northeast Japan. The study protocol was approved by our University Ethical Committee, and written informed consent was obtained from all participants. Central blood pressure was estimated noninvasively using the SphygmoCor (PWV Medical). Radial blood pressure was calibrated from SBP and diastolic blood pressure using an oscillometric brachial artery cuff system. All measurements were performed with subjects supine, and after at least 5 min of resting time. The study also included Doppler echocardiography, and left ventricular hypertrophy was defined by established partition mass index values (4110 g/m 2 for women, 4134 g/m 2 for men). Since several cardiovascular medications such as antihypertensive drugs and nitrates have been reported to modify peripheral SBP without significant effects on central SBP, 3 subjects receiving these types of drugs were excluded from the present analysis. Subjects having apparent structural heart disease were also excluded. The analysis was thus based on 706 community dwelling men and women (mean age 56710 years; men ¼ 344, women ¼ 362).
Peripheral-central SBP difference was calculated from radial artery SBP minus central SBP derived from SphygmoCor. To study the relationships between peripheral-central SBP amplification and a range of clinical characteristics, participants were divided into quartile groups according to peripheral-central SBP difference. To examine the odds ratio of clinical characteristics predicting subjects in the lowest 10 percentile for peripheral-central SBP difference, relevant clinical characteristics were entered into a multivariate logistic regression model. The significance of the difference was analysed by one-way ANOVA or w 2 -test. Data were shown as mean7standard deviation. Figure 1 shows a histogram of peripheral-central SBP difference. The difference ranged from 1 to 33 mmHg with a median value of 8 mmHg. Table 1 shows a number of clinical characteristics among the quartile groups according to radial-central SBP difference. The ratio of women in the Q1 group was significantly higher than in the Q4 group (Po0.001). The percentage of subjects aged over 65 years was higher in Q1-Q3 than in Q4 (Po0.05). The prevalence of short stature in Q1 was higher than in Q4 (Po0.001). Pulse rate was significantly lower in Q1 than in the other quartiles (Po0.001). The percentage of bradycardia was significantly higher in Q1 (33.5%) than in Q2-Q4 (9.7-18.3%) (Po0.001). The prevalence of left ventricular hypertrophy was not significant among the quartiles, possibly due to the low prevalence rate in the present cohort ( The present study has found that bradycardia is the clinical characteristic most powerfully associated with a diminution in peripheral-central SBP difference. Changes in pulse rate are known to affect pressure waveform and therefore blood pressure. One previous study 4 has demonstrated that a rapid pacemaker-induced increase in pulse rate augmented peripheral SBP without significant changes in aortic stiffness and central SBP in elderly patients with cardiovascular disease. This study showed a decrease in travelling time from the foot of the pressure wave to the inflection point during pacing, and suggests that an increase in pulse rate seems to alter the site of pressure wave reflection and/or reflection coefficient levels. The present study has also revealed that short stature (defined as below the average for each sex) was correlated with low levels of central to peripheral SBP amplification. Smulyan et al 5 have shown body height to be a determinant of timing and magnitude of reflected waves and suggested the early systolic arrival of increased reflected waves. These haemodynamic alterations may be an important factor underlying low peripheral-central SBP difference.
Female sex was found to be correlated with reduced central-peripheral SBP amplification. Since short stature was defined by sex-specific averages, there should be no significant confounding effects between sex and short stature in our analysis. Gatzka et al 6 have compared aortic diameter and aortic stiffness between age-and heightmatched men and women, and found that women have smaller and stiffer arterial vessels. This suggests that these differing arterial characteristics may cause greater arterial wave reflection and thus the SBP difference in women.
Although this radial-to-aortic transfer function for estimation of central SBP and arterial wave reflection (augmentation index) has been reported to be valid, the accuracy of this approach for determination of aortic haemodynamic parameters has been disputed. 7 When a conventional fluid-filled catheter was employed to validate SphygmoCor-calculated aortic SBP, a systemic bias was reported between calculated and catheter-measured aortic SBP values. 8 However, one recent report 9 has shown that although aortic augmentation index values varied widely, aortic SBP values obtained from radial and carotid arteries using a transfer function were within acceptable limits of agreement. In conclusion, central-peripheral SBP amplification tends to be lower in short women with bradycardia in a blood pressure screening setting. Prediction of cardiovascular event risk may therefore be underestimated in subjects with these characteristics, when based on comparison of peripheral to central SBP values. Longitudinal studies will be required to further address this hypothesis.
